Title Revision n date

Similar documents
ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

Tenofovir disoproxil fumarate (Tenofoviri disoproxili fumaras)

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

ARTENIMOLUM ARTENIMOL. Adopted revised text for addition to The International Pharmacopoeia

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution

Lutein Esters from Tagetes Erecta

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010)

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

Draft proposal for The International Pharmacopoeia

Heparin Sodium ヘパリンナトリウム

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

THIN LAYER CHROMATOGRAPHY

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

Determination of 6-Chloropicolinic Acid (6-CPA) in Crops by Liquid Chromatography with Tandem Mass Spectrometry Detection. EPL-BAS Method No.

Flupyradifurone. HPLC Method

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

REVISED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA RETINOL CONCENTRATE, OILY FORM. (August 2010)

Revision Bulletin 28 Jul Aug 2017 Chemical Medicines Monographs 3

Compliance. Should you have any questions, please contact Behnaz Almasi, Associate Scientific Liaison ( or

PAPRIKA EXTRACT SYNONYMS DEFINITION DESCRIPTION FUNCTIONAL USES CHARACTERISTICS

Pharmacopeial Forum 818 INTERIM REVISION ANNOUNCEMENT Vol. 35(4) [July Aug. 2009] ERRATA

CHAPTER 2 SIMULTANEOUS DETRMINATION OF ANASTROZOLE AND TEMOZOLOMIDE TEMOZOLOMIDE CAPSULES 20 MG AND ANASTROZOLE TABLETS 1 MG

Development and Validation of Stability Indicating HPTLC Method for Estimation of Seratrodast

Ergovaline. [Methods listed in the Feed Analysis Standards] 1 Liquid chromatography Note 1, 2 [Feed Analysis Standards, Chapter 5, Section 2

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

10 Sulfaquinoxaline H N O S O. 4-amino-N-quinoxalin-2-ylbenzenesulfonamide C 14 H 12 N 4 O 2 S MW: CAS No.:

contents of the monograph in effect today. Please refer to the current edition of the USP NF for official text.

PROPOSAL FOR REVISION OF MONOGRAPH PUBLISHED IN The International Pharmacopoeia: REVISION OF ph test ABACAVIR ORAL SOLUTION (JULY 2012)

This revision also necessitates a change in the table numbering in the test for Organic Impurities.

CYCLOSERINE Proposal for revision of The International Pharmacopoeia (August 2012)

TENOFOVIRI DISOPROXILIS FUMARAS TENOFOVIR DISOPROXIL FUMARATE

Journal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article

Rebaudioside a From Multiple Gene Donors Expressed in Yarrowia Lipolytica

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Quetiapine Tablets. Expert Committee Monographs Chemical Medicines 4 Reason for Revision Compliance

Tramadol Hydrochloride Extended-Release Tablets. Expert Committee Chemical Medicines Monographs 2 Reason for Revision Compliance

EMTRICITABINE AND TENOFOVIR TABLETS

21 Virginiamycin OH O. For chickens (except for broilers) broilers. Added amount 5~15 5~15 10~20 10~20

Antioxidant. [Summary of antioxidant]

Relative Measurement of Zeaxanthin Stereoisomers by Chiral HPLC

SMOKE FLAVOURINGS. Wood smoke flavour, Smoke condensate

METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE

Hyderabad, India. Department of Pharmaceutical Chemistry, Glocal University, Saharanpur, India.

STANDARD OPERATING PROTOCOL (SOP)

FLUNITRAZEPAM Latest Revision: January 24, 2006

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA EFAVIRENZ, EMTRICITABINE AND TENOFOVIR TABLETS

OLEANDER FOR HOMOEOPATHIC PREPARATIONS NERIUM OLEANDER FOR HOMOEOPATHIC PREPARATIONS

Diltiazem Hydrochloride Extended-Release Capsules. Type of Posting Posting Date Official Date

HPLC Analysis of Sugars

CLINDAMYCIN PHOSPHATE (CLINDAMYCINI PHOSPHAS) REVISED DRAFT MONOGRAPH FOR INCLUSION IN The International Pharmacopoeia (August 2016)

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

CHAPTER 3: ANALYTICAL METHOD DEVELOPMENT AND VALIDATION

AMERICAN SPIKENARD FOR HOMOEOPATHIC PREPARATIONS ARALIA RACEMOSA FOR HOMOEOPATHIC PREPARATIONS

ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS

E17 ETHYLCELLULOSE. Revision 3 Stage 4

3-Acetyldeoxynivalenol. 15-Acetyldeoxynivalenol

CORESTA Recommended Method No. 78

SIMAROUBA CEDRON FOR HOMOEOPATHIC PREPARATIONS CEDRON FOR HOMOEOPATHIC PREPARATIONS

PROPOSAL FOR REVISION OF MONOGRAPH IN THE FOURTH EDITION OF The International Pharmacopoeia MEFLOQUINE HYDROCHLORIDE (JANUARY 2012) DRAFT FOR COMMENT

ABACAVIR SULFATE Proposal for revision of The International Pharmacopoeia (August 2012)

EASI-EXTRACT BIOTIN Product Code: P82 / P82B

Should you have any questions, please contact Heather Joyce, Ph.D., Senior Scientific Liaison ( or

ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS ABSINTHIUM FOR HOMOEOPATHIC PREPARATIONS

The International Pharmacopoeia TENOFOVIR DISOPROXIL FUMARATE (JULY 2012)

SUCROSE OLIGOESTERS TYPE I

Application Note. Author. Abstract. Introduction. Food Safety

19 Nosiheptide S O. For chickens (excluding broilers) For broilers. Finishing period broilers Growing period broilers. Stating chicks Growing chicks

HYDROXYPROPYLCELLULOSE, LOW SUBSTITUTED Stage 4, Revision 1 CP: USP BRIEFING NOTE

Analysis of Amino Acids Derived Online Using an Agilent AdvanceBio AAA Column

ANALYTICAL TECHNIQUES FOR THE QUALITY OF ANTI- AIDS DRUGS

Neosolaniol. [Methods listed in the Feed Analysis Standards]

Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

CORESTA RECOMMENDED METHOD NÄ 9

Pelagia Research Library

Pelagia Research Library

World Journal of Pharmaceutical Research

STABILITY INDICATING ASSAY. differentiate an intact drug from its potential decomposition products 425.

Application Note Soy for Isoflavones by HPLC. Botanical Name: Glycine max L. Common Names: Parts of Plant Used: Beans.

CHAPTER 8 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) ANALYSIS OF PHYTOCHEMICAL CONSTITUENTS OF M. ROXBURGHIANUS AND P. FRATERNUS PLANT EXTRACTS

EXPERIMENT 13: Isolation and Characterization of Erythrocyte

MONOGRAPHS (NF) Pharmacopeial Forum 616 HARMONIZATION Vol. 31(2) [Mar. Apr. 2005]

GB Translated English of Chinese Standard: GB NATIONAL STANDARD OF THE

Official Journal of the European Union. (Non-legislative acts) REGULATIONS

Study of the British Pharmacopeia method on methimazole (thiamazole) content in carbimazole tablets

Journal of Chemical and Pharmaceutical Research

(ACE) inhibitor class that is primarily used in cardiovascular. conditions. Lisinopril was introduced into therapy in the early

Telmisartan and Hydrochlorothiazide Tablets. Type of Posting. Revision Bulletin Posting Date. 26 Jan 2018 Official Date

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

International Journal of Drug Research and Technology

MONOGRAPHS (USP) Saccharin Sodium

Journal of Chemical and Pharmaceutical Research, 2017, 9(9): Research Article

Transcription:

A. THIN LAYER CHROMATOGRAPHIC TECHNIQUE (TLC) 1. SCOPE The method describes the identification of hydrocortisone acetate, dexamethasone, betamethasone, betamethasone 17-valerate and triamcinolone acetonide in cosmetic products. 2. PRINCIPLE Liquid samples suspected of containing steroid compounds are neutralized and extracted with ethyl acetate. Cream samples suspected of containing steroid compounds are extracted with methanol. The extracted solutions are evaporated to dryness. Residues are dissolved in methanol for identification by thin layer chromatographic technique. 3. REAGENTS All reagents must be of analytical grade. 3.1. Dichloromethane 3.2. Methyl acetate 3.3. Water 3.4. Methanol 3.5. Anisaldehyde 3.6. Sulfuric acid (concentrated) 3.7. Hydrochloric acid (0.5 M) 3.8. Ammonium hydroxide (0.5 M) 3.9. Glacial acetic acid 3.10. Tetrazolium blue 3.11. Sodium hydroxide (pellets) 3.12. Ethyl acetate 3.13. Developing solvent: Dichloromethane/Methyl Acetate /Water, 100:50:50 Use the lower layer of the mixture. 3.14. Reference materials: 3.14.1. Hydrocortisone acetate 3.14.2. Dexamethasone 3.14.3. Betamethasone 3.14.4. Betamethasone 17-valerate 3.14.5. Triamcinolone acetonide 3.15. Standard solutions 3.15.1. Weigh 10 mg of every reference material into separate 10 ml volumetric flask. Add 5 ml of methanol. Sonicate for 5 min, make up to volume with methanol. 3.15.2. Mixture of standard solutions: weigh 10 mg of every reference material into one 10 ml volumetric flask. Add 5 ml methanol. Sonicate for 5 min and make up to volume with methanol. 3.16. Spray reagents 3.16.1. Into a 100 mlvolumetric flask, add 50 ml glacial acetic acid. Then, add 0.5 ml anisaldehyde, and finally 11 ml sulfuric acid. Shake gently. Page 1/1

3.16.2. Other spray reagent for information: Alkaline tetrazolium blue solution : mix 10 ml of a 0.2% w/v solution of tetrazolium blue in methanol with 30 ml of a 12% w/v solution of sodium hydroxide in methanol (this solution should be freshly prepared). 4. APPARATUS Normal laboratory equipment, and: 4.1. TLC plates, ready for use: silica gel 60 F254 nm 4.2. TLC tank 4.3. Ultrasonic bath 4.4. UV lamp 254 nm 4.5. Oven 4.6. Filter paper, 1 PS or equivalent 4.7. Water bath 4.8. Shaker 4.9. ph meter 4.10. 0.45 µm syringe membrane filter, PVDF or equivalent 5. PROCEDURE 5.1 Preparation of the sample 5.1.1 Liquid Sample Take about 15 ml of sample. Neutralize to ph 7 with 0.5 M HCl or 0.5 M NH 4 OH, extract 2 times with 20 ml ethyl acetate, discard aqueous layer. Filter if necessary - the combined extract into evaporating dish and evaporate to dryness in a water bath (indication time: 30 min). Dissolve the residue in 5 ml of methanol and filter using the syringe membrane filter. 5.1.2 Cream Sample Weigh about 5 g of sample in a centrifuge tube and dissolve by adding 20 ml of methanol. Warm on water bath for 10 minutes and shake vigorously for 5 minutes using a shaker. Centrifuge at 3000 4000 rpm for 10 minutes and leave it in the freezer for 10 minutes. Evaporate the clear supernatant solution to dryness in the water bath (indication time: 1h). Dissolve the residue in 5mL of methanol and filter the solution using the syringe membrane filter. 5.2 TLC 5.2.1 Saturate a chromatographic tank with the developing solvent. 5.2.2 On a plate, deposit: 20 µl of every reference solution, 20 µl of the mixture of reference solutions, 20 µl of the sample solution. Develop until the solvent front has migrated 15 cm from the start. 5.2.3 Remove the plate and allow to dry at room temperature. 5.3 Detection Page 2/2

5.3.1 Observe the plate under UV light at 254 nm, and mark the position of the spots. 5.3.2 Spray the plate with reagent 3.16.1. Let it dry and put the plate in the oven at 120 C for 10 min and observe the spots. 6. INTERPRETATION OF RESULT Colour of spot Estimated Rf Steroids Spray reagent 3.16.1 Spray reagent 3.16.2 hydrocortisone acetate dark brown violet blue 0.4 dexamethasone grey violet blue 0.2 betamethasone greyish blue violet blue 0.2 triamcinolone acetonide yellow green violet blue 0.3 betamethasone 17- valerate dark purple violet blue 0.35 7. REMARKS 7.1 This method is also applicable to identify the following steroids; cortisone acetate, prednisolone, prednisone, flucinolone acetonide, betamethasone 21-valerate, hydrocortisone. 7.2 Further screening by HPLC shall be carried out. 7.3 The limit of detection (LOD) shall be reported. B. HPLC TECHNIQUE 1. SCOPE This method specifies a procedure for further identification of hydrocortisone acetate, dexamethasone, betamethasone, betamethasone 17-valerate and triamcinolone acetonide in cosmetic products. 2. PRINCIPLE Liquid samples suspected of containing steroid compounds are neutralized and extracted with ethyl acetate. Cream samples suspected of containing steroid compounds are extracted with methanol. The extracted solutions are evaporated to dryness. Residues are dissolved in methanol for identification by reversed phase liquid chromatography with UV detection. 3. REAGENTS All reagents must be of analytical quality. Water used must be distilled water, or water of at least equivalent purity 3.1 Acetonitrile, HPLC grade 3.2 Ammonium hydroxide (0.5 M) 3.3 Methanol, HPLC grade 3.4 Ethyl acetate 3.5 Hydrochloric acid (0.5 M) 3.6 Mobile phase : Acetonitrile : Water Page 3/3

Gradient : Title Revision n date Time (min) Ratio (%) Acetonitrile Water 0.01 15.00 30 70 15.01 21.00 60 40 21.01 30.00 50 50 30.01 34.99 30 70 35.00 STOP Note: the above gradient conditions should be adjusted when necessary to the type of column in use. 3.7 Reference materials 3.7.1 Hydrocortisone acetate 3.7.2 Dexamethasone 3.7.3 Betamethasone 3.7.4 Betamethasone 17-valerate 3.7.5 Triamcinolone acetonide 3.8 Standard solutions 3.8.1 Weigh 10 mg of every reference material into separate 10 ml volumetric flask. Add 5 ml of methanol. Sonicate for 5 minutes, make up to volume with methanol. Filter using a syringe membrane filter. 3.8.2 Mixture of standard solutions: weigh 10 mg of every reference material into one 10 ml volumetric flask. Add 5 ml methanol. Sonicate for 5 minutes and make up to volume with methanol. Filter using a syringe membrane filter. 4. APPARATUS Normal laboratory equipment and: 4.1 Water bath, capable of maintaining a temperature of 60 C 4.2 High-performance liquid chromatograph with a variable wavelength UV detector and 20 µl injection loop 4.3 Analytical column Stainless steel chromatographic column, length 250 mm, internal diameter 4,6 mm, (packed with ODS), particle size 5 µm, or equivalent. 4.4 Filter paper, 1 PS or equivalent 4.5 Ultrasonic bath 4.6 Shaker 4.7 ph meter 4.8 Syringe membrane filter (0.45 µm pore size) 5. PROCEDURE 5.1 Sample preparation 5.1.1 Liquid Sample Take about 15 ml of sample. Neutralize to ph 7 with 0.5 M HCl or 0.5 M NH 4 OH, extract 2 times with 20 ml ethyl acetate, discard aqueous layer. Filter if necessary - the combined extract into evaporating dish and evaporate to dryness in a water bath (indication time: 30 min). Dissolve the residue in 5 ml of methanol and filter using the syringe membrane filter. Page 4/4

5.1.2 Cream Sample Weigh about 5 g of sample in a centrifuge tube and dissolve by adding 20 ml of methanol. Warm on water bath for 10 minutes and shake vigorously for 5 min using a shaker. Centrifuge at 3000 4000 rpm for 10 min and leave it in the freezer for 10 min. Evaporate the clear supernatant solution to dryness in the water bath (indication time: 1h). Dissolve the residue in 5mL of methanol and filter the solution using the syringe membrane filter. 5.2 High performance liquid chromatography 5.2.1 Adjust the flow rate of the mobile phase to 1.2 ml/min and set the detector wavelength to 245 nm. 5.2.2 Inject 20 µl of every reference solution, 20 µl of the mixture of reference solutions, 20 µl of the sample solution. 5.2.3 System suitability The relative standard deviation (RSD) of the retention time should be less than 1%, and the RSD of 6 replicate injections should be less than 2%. 5.2.4 Compare the retention time of the chromatograms obtained for sample and reference solutions. 6. INTERPRETATION 6.1 The retention time of reference and sample solution should not differ by more than ± 1 %. 6.2 The estimated retention (RT) for the steroids are as follows: Steroids Estimated retention time (RT) (min) Betamethasone 15 Dexamethasone 16 Triamcinolone Acetonide 19 Hydrocortisone Acetate 20 Betamethasone 17-valerate 22 7. Limit of detection (LOD) and limit of quantitation (LOQ): Page 5/5

Steroids Hydrocortisone Acetate Triamcinolone Acetonide Betamethasone Dexamethasone Betamethasone 17-valerate Standards (mg/ml) 0.02 0.04 0.05 0.05 LOD Samples Liquid (µg/ml) 7 14 17 17 Cream (µg/g) 20 40 50 50 Standards (mg/ml) 0.07 0.13 0.15 0.16 LOQ Samples Liquid (µg/ml) 23 46 58 62 Cream (µg/g) 70 130 150 160 8. REMARKS This method is also applicable to identify the following steroids; cortisone acetate, prednisolone, prednisone, flucinolone acetonide, betamethasone 21-valerate and hydrocortisone C. CONCLUSION Combine the results from TLC and HPLC to identify the presence of the steroids within the scope of the method.. Harmonised method: Issued by the chemical analysis group at the harmonization workshop in Kuala- Lumpur, on September 13 th to 17 th, 2004 Approved by the harmonization workshop delegates workshop in Kuala-Lumpur, on September 13 th to 17 th, 2004, Modified after the Kuala-Lumpur training, Dec 6 th to Dec 10 th, 2004 Modified and approved after the Brunei workshop, Aug 30 th to 31 st, 2005 Modified and approved after the final review in Singapore, Nov 30 th to Dec 2 nd, 2005 Page 6/6